LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Weight Gain After 12 Months of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV Patients.

Pérez-Barragán, Edgar / Guevara-Maldonado, Mónica Fernanda / Mancilla-Galindo, Javier / Kammar-García, Ashuin / Ortiz-Hernández, Alejandro / Mata-Marín, José Antonio / Pérez-Cavazos, Samantha

AIDS research and human retroviruses

2023  Volume 39, Issue 10, Page(s) 511–517

Abstract: Recent studies suggest that the introduction of antiretroviral agents such as integrase strand transfer inhibitors (INSTI) may lead to weight gain in people living with HIV (PLHIV). In this retrospective observational study, we report the weight changes ... ...

Abstract Recent studies suggest that the introduction of antiretroviral agents such as integrase strand transfer inhibitors (INSTI) may lead to weight gain in people living with HIV (PLHIV). In this retrospective observational study, we report the weight changes observed in virologically suppressed HIV patients after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) due to a national change in public policy in Mexico. Patients on prior regimens based on TDF/FTC or ABC/3TC plus non-nucleoside retrotranscriptase inhibitor, INSTI, or protease inhibitor were included. In the 399 patients analyzed, a significant weight increase was found, as well as an increase in body mass index (BMI), total cholesterol, low-density lipoprotein cholesterol (LDL-C), glucose, creatinine, and CD4
MeSH term(s) Humans ; Adenine ; Anti-HIV Agents/adverse effects ; Cholesterol ; Drug Combinations ; Emtricitabine/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; HIV Infections/drug therapy ; Weight Gain
Chemical Substances Adenine (JAC85A2161) ; Anti-HIV Agents ; bictegravir (8GB79LOJ07) ; Cholesterol (97C5T2UQ7J) ; Drug Combinations ; Emtricitabine (G70B4ETF4S) ; Heterocyclic Compounds, 3-Ring ; tenofovir alafenamide (EL9943AG5J)
Language English
Publishing date 2023-05-29
Publishing country United States
Document type Observational Study ; Journal Article
ZDB-ID 639130-8
ISSN 1931-8405 ; 0889-2229
ISSN (online) 1931-8405
ISSN 0889-2229
DOI 10.1089/AID.2022.0130
Shelf mark
Zs.A 1928: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top